Small Molecule Drug Product Leads
A detailed analysis of UPM Pharmaceuticals' small molecule drug product capabilities enabled the company to craft a focused lead generation strategy for new business development. This intricate evaluation of UPM's strengths, including formulation expertise, manufacturing capabilities, and scalability, helped identify potential clients who would benefit most from its services. By leveraging this data, UPM was able to create a highly targeted pipeline of leads, aimed specifically at companies in North America seeking specialized small molecule drug development and manufacturing solutions.
